Superior Vena Cava Syndrome as the presenting form of Germ-cell Tumour

Authors

  • Rui Garcia Interno Complementar de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Rita Monteiro Interno Complementar de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Jaquelina Santos Interna Complementar de Clínica Geral e Medicina Familia
  • Jorge Velez Assistente Hospitalar Graduado de Medicina Interna dos Hospitais da Universidade de Coimbra
  • Armando Carvalho § Chefe de Serviço de Medicina Interna dos Hospitais da Universidade de Coimbra e Professor Associado com Agregação da Faculdade de Medicina da Universiade de Coimbra
  • Nascimento costa Director do Serviço de Medicina III dos Hospitais da Universidade de Coimbra; Professor Associado com Agregação da Faculdade de Medicina da Universidade de Coimbra

Keywords:

Superior vena cava syndrome, germ-cell tumour

Abstract

The authors present a patient with superior vena cava syndrome, of sudden evolution, as the presenting form of a histologically
proven germ-cell tumour. The first therapeutic attitude was endovascular stenting of the SVC to improve symptoms without
compromising further strategies. After obtaining the definitive diagnosis, therapeutic approach was chemotherapy with BEP.

Downloads

Download data is not yet available.

References

Escalante, CP. Causes and managment of superior vena cava syndrome. Oncology (Williston Park) 1993; 7 (6):61-68.

Urban T, Lebeau B, Chastang C et al. Superior vena cava syndrome in smallcell lung cancer. Arch Intern Med 1993; 153:384-387.

Yellin A, Rosen A, Reichert N, Liebermen Y. Superior vena cava syndrome. The myth-the facts. Am Rev Respir Dis 1990; 141:1114-1117.

Courtheoux P, Alkofer B, Al Refai M et al. Stent placement in superior vena cava syndrome; Ann Thorac Surg 2003; 75:158-161.

Balzer BL, Ulbright TM. Spontaneous regression of testicular germ cell tumours; an analysis of 42 cases; Am J Surg Pathol 2006; 30:858-865.

Bokemeyer C, Droz JP, Horwich A et al; Extragonadal seminoma. An international multicenter analysis of prognostic factors and long term treatment outcome; Cancer 2001; 91:1394-1401.

Hidalgo M, Paz-Ares L, Rivera F e tal; Mediastinal non-seminomatous germ-cell tumours treated with cisplatinum-based combination chemotherapy. Ann Oncol 1997; 8:555.

Walsh GL, Taulor GD, Nesbitt JC, Amato RJ. Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ-cell tumours; Ann Thorac Surg 2000; 69:337-343.

Vuky J, Bains M, Bacik J et al. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum; J Clin Oncol 2001; 19:682-688.

International Germ-cell Consensus Classification: A prognostic factorbased staging system for metastatic germ-cell cancers. International Germ-cell Cancer collaborative Group; J Clin Oncol 1997; 15:594-603.

Cameron RB, Loehrer PJ, Thomas CR. Neoplasms of mediastinum. In: Cancer: Principles and Practice of Oncology; Lippincort Williams Wilkins; New York 2001

Additional Files

Published

2008-12-31

How to Cite

1.
Garcia R, Monteiro R, Santos J, Velez J, Carvalho A, costa N. Superior Vena Cava Syndrome as the presenting form of Germ-cell Tumour. RPMI [Internet]. 2008 Dec. 31 [cited 2024 Sep. 7];15(4):259-62. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1489

Issue

Vol. 15 No. 4 (2008): Outubro/ Dezembro

Section

Case Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Most read articles by the same author(s)

1 2 > >>